Chilton Labs Tirzepatide 20mg Vial (R&D Only)

Product Description

The Chilton Labs Tirzepatide 20mg vial is a premium-quality, research-grade peptide developed for advanced laboratory and scientific studies. Manufactured to high purity standards and supplied as a lyophilised powder, this compound is widely studied for its interaction with metabolic pathways and incretin receptor activity.

Tirzepatide is a dual GLP-1 and GIP receptor agonist, making it a key compound in metabolic and endocrine research models.

Each vial is carefully sealed, batch-tested, and includes access to a Certificate of Analysis (COA) to ensure identity, purity, and consistency.

---

Short Product Description

High-purity Chilton Labs Tirzepatide 20mg vial designed for UK research use. Dual incretin receptor peptide supplied with COA for verified laboratory studies.

---

Key Features

• 20mg Tirzepatide per vial
• High-purity research-grade peptide (≥99%)
• Lyophilised (freeze-dried) powder for stability
• COA verification for every batch
• Secure, discreet UK shipping
• Stored under controlled conditions for maximum integrity

---

Ingredients / Composition

• Active Compound: Tirzepatide (synthetic peptide)
• Molecular Weight: ~4813 g/mol
• Form: White to off-white lyophilised powder
• No added fillers or active excipients (research-grade standard)

---

Benefits (Research Context)

In controlled laboratory environments, Tirzepatide is studied for:

• Dual activation of GLP-1 & GIP receptors
• Metabolic pathway signalling and insulin sensitivity
• Appetite and satiety regulatory mechanisms
• Glucose metabolism and endocrine research models
• Energy balance and lipid metabolism studies

Its dual receptor activity distinguishes it from single-pathway peptides, making it highly valuable in metabolic research.

---

Recommended Usage (Research Only)

• Intended strictly for laboratory research and analytical use
• Reconstitute using sterile bacteriostatic water under controlled lab conditions
• Store lyophilised vial at -18°C or below, refrigerate after reconstitution (2–8°C)
• Follow institutional and regulatory laboratory protocols

---

Stacking Options (Research Studies)

Researchers often explore Tirzepatide alongside:

• Retatrutide (triple agonist pathway research)
• AOD-9604 (fat metabolism studies)
• MOTS-C (mitochondrial research peptide)

Stacking is strictly for experimental research modelling, not for consumption.

---

Safety & Precautions

• ⚠️ For Research & Development use only
• Not for human or veterinary use
• Handle using appropriate laboratory PPE
• Maintain sterile preparation conditions
• Ensure proper storage to prevent degradation

⚠️ Note: Unregulated peptide markets may contain impurities or incorrect dosages, highlighting the importance of sourcing from trusted suppliers.